Therapeutic applications of TRAIL receptor agonists in cancer and beyond-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic applications of TRAIL receptor agonists in cancer and beyond

Published:2015-11 Issue: Volume:155 Page:117-131
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Amarante-Mendes Gustavo P.,Griffith Thomas S.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Brazilian Research Council (CNPq)

National Institutes of Health

U.S. Department of Veterans Affairs Merit Review Program

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference320 articles.

1. Wild-type measles virus infection upregulates poliovirus receptor-related 4 and causes apoptosis in brain endothelial cells by induction of tumor necrosis factor-related apoptosis-inducing ligand;Abdullah;J Neuropathol Exp Neurol,2013

2. Human tumor necrosis factor;Aggarwal;Methods Enzymol,1985

3. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL;Aktas;Neuron,2005

4. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells;Albert;Nat Immunol,2001

5. Fas ligand mediates activation-induced cell death in human T lymphocytes;Alderson;J Exp Med,1995

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aponermin: First Approval;Drugs;2024-03-05

2. Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics;Biochemical Pharmacology;2024-03

3. Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes;Pharmaceutical Development and Technology;2024-01-02

4. Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer;Frontiers in Immunology;2023-12-07

5. Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: a bidirectional Mendelian randomization study;Clinical and Experimental Medicine;2023-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3